Peripheral Blood Biomarkers and Response to Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma
Clinical trial NCT07734857 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07734857
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-07-10
- Primary completion
- 2028-07-10
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.